Diagnamed Holdings Corp.

CNSX:DMED Stock Report

Market Cap: CA$1.6m

Diagnamed Holdings Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Fabio Chianelli

Chief executive officer

CA$180.0k

Total compensation

CEO salary percentagen/a
CEO tenure3.3yrs
CEO ownership9.9%
Management average tenureno data
Board average tenure3.1yrs

Recent management updates

Recent updates


CEO

Fabio Chianelli (46 yo)

3.3yrs

Tenure

CA$180,000

Compensation

Mr. Fabio Chianelli is the Founder of PharmaTher Holdings Ltd. (formerly known as Newscope Capital Corporation) (formerly known as PharmaTher Inc.). and serves as its Chief Executive Officer since June 03,...


Board Members

NamePositionTenureCompensationOwnership
Fabio Chianelli
Chairman3.3yrsCA$180.00k9.93%
CA$ 159.0k
Ming Jang
Independent Director2.9yrsno datano data
Carlo Sansalone
Independent Non-Executive Director1.8yrsno data2.5%
CA$ 40.0k
Elyssia Patterson
Independent Director3.7yrsno data0.13%
CA$ 2.0k

3.1yrs

Average Tenure

46yo

Average Age

Experienced Board: DMED's board of directors are considered experienced (3.1 years average tenure).